Yuanquan Yang
Clinical trials sponsored by Yuanquan Yang, explained in plain language.
-
New drug duo aims to shrink tough bladder tumors before surgery
Disease control Recruiting nowThis study is testing a combination of two drugs, futibatinib and durvalumab, given to patients before they have surgery to remove their bladder (cystectomy). The goal is to see if this treatment can shrink or eliminate the cancer in the bladder before it is surgically removed. I…
Phase: PHASE2 • Sponsor: Yuanquan Yang • Aim: Disease control
Last updated Apr 04, 2026 00:35 UTC
-
New approach aims to shield patients from dangerous side effects when restarting cancer treatment
Disease control Recruiting nowThis study is testing whether adding a drug called siltuximab can help cancer patients safely restart a type of immunotherapy that previously caused them severe side effects. The trial will enroll 40 adults with advanced cancer who had to stop their original immunotherapy due to …
Phase: PHASE2 • Sponsor: Yuanquan Yang • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC